Online Inquiry
Cat.#: ACPP-1074
| Despition | Myocilin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1051 | Recombinant Human Amyloid Precursor Protein Protein (6×His Tag) (AC1051) | 50 µg | inquiry |
| ACPP-1563 | Human STX4 Protein (AC1563) | 5 µg | inquiry |
| ACPP-1334 | DRP1 Blocking Peptide (AC1334) | 250 µg | inquiry |
| ACPP-1806 | Human SCGN Protein (AC1806) | 2 µg | inquiry |
| ACPP-1081 | Human NRN1 Protein (AC1081) | 5 µg | inquiry |
| ACPP-1687 | Mouse Visfatin Protein (AC1687) | 5 µg | inquiry |
| ACPP-1054 | Recombinant Human Neuroglycan C Protein (6×His Tag) (AC1054) | 50 µg | inquiry |
| ACPP-1288 | C9orf72 Blocking Peptide (AC1288) | 250 µg | inquiry |
| ACPP-1289 | Usherin Blocking Peptide (AC1289) | 250 µg | inquiry |
| ACPP-1236 | SOX2 Blocking Peptide (AC1236) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.